Hopital Robert Schuman

Vantoux 57070

0 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Idiopathic Pulmonary Fibrosis, Neoplasms, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer — Completed
• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• A Study to Investigate Leramistat in Patients With IPF — Withdrawn before enrolling